nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—bipolar disorder—Topiramate—obesity	0.267	1	CpDpCtD
Ziprasidone—DRD4—obesity	0.0495	0.196	CbGaD
Ziprasidone—HTR1B—obesity	0.0439	0.174	CbGaD
Ziprasidone—DRD1—obesity	0.0419	0.165	CbGaD
Ziprasidone—HTR2C—obesity	0.0358	0.142	CbGaD
Ziprasidone—SLC6A4—obesity	0.0297	0.117	CbGaD
Ziprasidone—DRD2—obesity	0.0295	0.117	CbGaD
Ziprasidone—SLC6A4—Sibutramine—obesity	0.0245	0.0867	CbGbCtD
Ziprasidone—HTR2A—obesity	0.0228	0.0901	CbGaD
Ziprasidone—ADRA1B—Phendimetrazine—obesity	0.0224	0.0794	CbGbCtD
Ziprasidone—DRD1—Phenylpropanolamine—obesity	0.0202	0.0716	CbGbCtD
Ziprasidone—SLC6A4—Phentermine—obesity	0.0186	0.0657	CbGbCtD
Ziprasidone—ADRA1A—Phendimetrazine—obesity	0.0177	0.0627	CbGbCtD
Ziprasidone—ADRA2C—Methamphetamine—obesity	0.017	0.06	CbGbCtD
Ziprasidone—ADRA2B—Methamphetamine—obesity	0.0161	0.0569	CbGbCtD
Ziprasidone—SLC6A4—Methamphetamine—obesity	0.0148	0.0525	CbGbCtD
Ziprasidone—ADRA2A—Benzphetamine—obesity	0.014	0.0495	CbGbCtD
Ziprasidone—ADRA1A—Benzphetamine—obesity	0.0134	0.0475	CbGbCtD
Ziprasidone—ADRA2A—Phenylpropanolamine—obesity	0.0134	0.0473	CbGbCtD
Ziprasidone—ADRA1A—Phenylpropanolamine—obesity	0.0128	0.0453	CbGbCtD
Ziprasidone—ADRA2A—Methamphetamine—obesity	0.0112	0.0396	CbGbCtD
Ziprasidone—CYP3A7-CYP3A51P—Cimetidine—obesity	0.00631	0.0224	CbGbCtD
Ziprasidone—CYP3A7—Cimetidine—obesity	0.00631	0.0224	CbGbCtD
Ziprasidone—CYP1A2—Phentermine—obesity	0.00565	0.02	CbGbCtD
Ziprasidone—CYP1A2—Phenylpropanolamine—obesity	0.00539	0.0191	CbGbCtD
Ziprasidone—HTR3A—area postrema—obesity	0.00509	0.185	CbGeAlD
Ziprasidone—CYP1A2—Bupropion—obesity	0.0048	0.017	CbGbCtD
Ziprasidone—CYP3A5—Cimetidine—obesity	0.00474	0.0168	CbGbCtD
Ziprasidone—CYP2D6—Phentermine—obesity	0.00465	0.0165	CbGbCtD
Ziprasidone—CYP2D6—Bupropion—obesity	0.00396	0.014	CbGbCtD
Ziprasidone—CYP3A4—Sibutramine—obesity	0.00391	0.0138	CbGbCtD
Ziprasidone—CYP2D6—Methamphetamine—obesity	0.00372	0.0132	CbGbCtD
Ziprasidone—CYP1A2—Cimetidine—obesity	0.00353	0.0125	CbGbCtD
Ziprasidone—CYP3A4—Benzphetamine—obesity	0.00296	0.0105	CbGbCtD
Ziprasidone—CYP2D6—Cimetidine—obesity	0.0029	0.0103	CbGbCtD
Ziprasidone—CYP3A4—Bupropion—obesity	0.00252	0.00891	CbGbCtD
Ziprasidone—CYP3A4—Orlistat—obesity	0.00205	0.00726	CbGbCtD
Ziprasidone—CYP3A4—Cimetidine—obesity	0.00185	0.00654	CbGbCtD
Ziprasidone—HTR3A—vagus nerve—obesity	0.0017	0.0617	CbGeAlD
Ziprasidone—CHRM3—muscle of abdomen—obesity	0.00145	0.0525	CbGeAlD
Ziprasidone—CYP3A4—Topiramate—obesity	0.00121	0.00428	CbGbCtD
Ziprasidone—HTR7—sympathetic nervous system—obesity	0.00113	0.0412	CbGeAlD
Ziprasidone—HTR7—vagus nerve—obesity	0.0011	0.0399	CbGeAlD
Ziprasidone—HTR7—autonomic nervous system—obesity	0.000762	0.0277	CbGeAlD
Ziprasidone—HTR2A—sympathetic nervous system—obesity	0.000707	0.0257	CbGeAlD
Ziprasidone—HTR2A—vagus nerve—obesity	0.000685	0.0249	CbGeAlD
Ziprasidone—HTR2A—autonomic nervous system—obesity	0.000475	0.0173	CbGeAlD
Ziprasidone—SLC6A4—hindbrain—obesity	0.000378	0.0137	CbGeAlD
Ziprasidone—H1F0—islet of Langerhans—obesity	0.000336	0.0122	CbGeAlD
Ziprasidone—HTR1A—hindbrain—obesity	0.000336	0.0122	CbGeAlD
Ziprasidone—Lurasidone—DRD2—obesity	0.000327	0.157	CrCbGaD
Ziprasidone—HTR7—hindbrain—obesity	0.000321	0.0117	CbGeAlD
Ziprasidone—HTR3A—islet of Langerhans—obesity	0.000321	0.0117	CbGeAlD
Ziprasidone—H1F0—respiratory system—obesity	0.000318	0.0115	CbGeAlD
Ziprasidone—ADRA1A—hindbrain—obesity	0.00031	0.0113	CbGeAlD
Ziprasidone—DRD2—hindbrain—obesity	0.000303	0.011	CbGeAlD
Ziprasidone—HTR3A—respiratory system—obesity	0.000303	0.011	CbGeAlD
Ziprasidone—H1F0—adrenal cortex—obesity	0.000267	0.00969	CbGeAlD
Ziprasidone—Lurasidone—HTR2A—obesity	0.000253	0.121	CrCbGaD
Ziprasidone—H1F0—cardiovascular system—obesity	0.000243	0.00884	CbGeAlD
Ziprasidone—SLC6A4—respiratory system—obesity	0.000231	0.0084	CbGeAlD
Ziprasidone—CYP3A7—endocrine gland—obesity	0.000225	0.00818	CbGeAlD
Ziprasidone—DRD5—endocrine gland—obesity	0.000216	0.00784	CbGeAlD
Ziprasidone—H1F0—pituitary gland—obesity	0.000215	0.00783	CbGeAlD
Ziprasidone—H1F0—adipose tissue—obesity	0.000215	0.0078	CbGeAlD
Ziprasidone—CYP3A7—liver—obesity	0.000203	0.00737	CbGeAlD
Ziprasidone—H1F0—digestive system—obesity	0.000202	0.00734	CbGeAlD
Ziprasidone—HTR2A—hindbrain—obesity	0.0002	0.00727	CbGeAlD
Ziprasidone—HTR7—respiratory system—obesity	0.000196	0.00712	CbGeAlD
Ziprasidone—HTR1B—cardiovascular system—obesity	0.000195	0.00707	CbGeAlD
Ziprasidone—CHRM2—cardiovascular system—obesity	0.000194	0.00704	CbGeAlD
Ziprasidone—KCNH2—islet of Langerhans—obesity	0.000193	0.00703	CbGeAlD
Ziprasidone—HTR3A—digestive system—obesity	0.000193	0.007	CbGeAlD
Ziprasidone—H1F0—adrenal gland—obesity	0.000192	0.00699	CbGeAlD
Ziprasidone—HTR1D—cardiovascular system—obesity	0.000188	0.00685	CbGeAlD
Ziprasidone—DRD2—respiratory system—obesity	0.000185	0.00674	CbGeAlD
Ziprasidone—CYP2D6—hindbrain—obesity	0.000182	0.00663	CbGeAlD
Ziprasidone—CHRM1—cardiovascular system—obesity	0.000176	0.00641	CbGeAlD
Ziprasidone—CYP3A7-CYP3A51P—liver—obesity	0.000173	0.00627	CbGeAlD
Ziprasidone—H1F0—endocrine gland—obesity	0.000167	0.00606	CbGeAlD
Ziprasidone—CYP3A5—islet of Langerhans—obesity	0.00016	0.0058	CbGeAlD
Ziprasidone—HTR1A—cardiovascular system—obesity	0.000157	0.00571	CbGeAlD
Ziprasidone—CYP1A2—respiratory system—obesity	0.000156	0.00568	CbGeAlD
Ziprasidone—ADRA2A—islet of Langerhans—obesity	0.000152	0.00553	CbGeAlD
Ziprasidone—ADRA2C—adrenal cortex—obesity	0.000151	0.0055	CbGeAlD
Ziprasidone—CYP3A5—respiratory system—obesity	0.000151	0.00548	CbGeAlD
Ziprasidone—H1F0—liver—obesity	0.00015	0.00547	CbGeAlD
Ziprasidone—HTR7—cardiovascular system—obesity	0.00015	0.00546	CbGeAlD
Ziprasidone—SLC6A4—digestive system—obesity	0.000147	0.00534	CbGeAlD
Ziprasidone—HRH1—respiratory system—obesity	0.000146	0.00532	CbGeAlD
Ziprasidone—ADRA1A—cardiovascular system—obesity	0.000145	0.00526	CbGeAlD
Ziprasidone—Clozapine—HRH3—obesity	0.000142	0.0682	CrCbGaD
Ziprasidone—KCNH2—cardiovascular system—obesity	0.00014	0.00508	CbGeAlD
Ziprasidone—CHRM3—adipose tissue—obesity	0.000139	0.00505	CbGeAlD
Ziprasidone—HTR1B—endocrine gland—obesity	0.000134	0.00485	CbGeAlD
Ziprasidone—CHRM2—endocrine gland—obesity	0.000133	0.00483	CbGeAlD
Ziprasidone—CHRM3—digestive system—obesity	0.000131	0.00476	CbGeAlD
Ziprasidone—Aripiprazole—DRD4—obesity	0.000131	0.0628	CrCbGaD
Ziprasidone—ADRA1A—adipose tissue—obesity	0.000128	0.00464	CbGeAlD
Ziprasidone—DRD2—pituitary gland—obesity	0.000126	0.00457	CbGeAlD
Ziprasidone—HTR7—digestive system—obesity	0.000125	0.00453	CbGeAlD
Ziprasidone—HTR1A—adrenal gland—obesity	0.000124	0.00452	CbGeAlD
Ziprasidone—KCNH2—pituitary gland—obesity	0.000124	0.0045	CbGeAlD
Ziprasidone—HTR2A—respiratory system—obesity	0.000122	0.00444	CbGeAlD
Ziprasidone—ADRA2C—pituitary gland—obesity	0.000122	0.00444	CbGeAlD
Ziprasidone—ADRA2C—adipose tissue—obesity	0.000122	0.00442	CbGeAlD
Ziprasidone—SLC6A4—endocrine gland—obesity	0.000121	0.00441	CbGeAlD
Ziprasidone—CHRM1—endocrine gland—obesity	0.000121	0.00439	CbGeAlD
Ziprasidone—HTR7—adrenal gland—obesity	0.000119	0.00432	CbGeAlD
Ziprasidone—Aripiprazole—HTR1B—obesity	0.000116	0.0558	CrCbGaD
Ziprasidone—ADRA1A—adrenal gland—obesity	0.000115	0.00416	CbGeAlD
Ziprasidone—Aripiprazole—DRD1—obesity	0.000111	0.0531	CrCbGaD
Ziprasidone—KCNH2—adrenal gland—obesity	0.000111	0.00402	CbGeAlD
Ziprasidone—ADRA2C—adrenal gland—obesity	0.000109	0.00397	CbGeAlD
Ziprasidone—CHRM3—endocrine gland—obesity	0.000108	0.00393	CbGeAlD
Ziprasidone—HTR1A—endocrine gland—obesity	0.000108	0.00392	CbGeAlD
Ziprasidone—HTR7—endocrine gland—obesity	0.000103	0.00374	CbGeAlD
Ziprasidone—Aripiprazole—ADRB1—obesity	0.000103	0.0493	CrCbGaD
Ziprasidone—CYP3A5—adipose tissue—obesity	0.000102	0.0037	CbGeAlD
Ziprasidone—CYP1A2—digestive system—obesity	9.94e-05	0.00361	CbGeAlD
Ziprasidone—ADRA1A—endocrine gland—obesity	9.93e-05	0.00361	CbGeAlD
Ziprasidone—HRH1—adipose tissue—obesity	9.89e-05	0.00359	CbGeAlD
Ziprasidone—ADRA2A—pituitary gland—obesity	9.75e-05	0.00354	CbGeAlD
Ziprasidone—DRD2—endocrine gland—obesity	9.74e-05	0.00354	CbGeAlD
Ziprasidone—ADRA2A—adipose tissue—obesity	9.71e-05	0.00353	CbGeAlD
Ziprasidone—KCNH2—endocrine gland—obesity	9.59e-05	0.00349	CbGeAlD
Ziprasidone—CYP3A5—digestive system—obesity	9.59e-05	0.00348	CbGeAlD
Ziprasidone—Aripiprazole—HTR2C—obesity	9.47e-05	0.0454	CrCbGaD
Ziprasidone—Trazodone—HTR2C—obesity	9.43e-05	0.0452	CrCbGaD
Ziprasidone—HTR2A—cardiovascular system—obesity	9.36e-05	0.0034	CbGeAlD
Ziprasidone—HRH1—digestive system—obesity	9.31e-05	0.00338	CbGeAlD
Ziprasidone—HTR7—liver—obesity	9.29e-05	0.00337	CbGeAlD
Ziprasidone—ADRA1A—liver—obesity	8.96e-05	0.00325	CbGeAlD
Ziprasidone—HRH1—adrenal gland—obesity	8.87e-05	0.00322	CbGeAlD
Ziprasidone—ADRA2A—adrenal gland—obesity	8.71e-05	0.00317	CbGeAlD
Ziprasidone—ADRA2C—liver—obesity	8.53e-05	0.0031	CbGeAlD
Ziprasidone—HTR2A—pituitary gland—obesity	8.29e-05	0.00301	CbGeAlD
Ziprasidone—CYP1A2—endocrine gland—obesity	8.21e-05	0.00298	CbGeAlD
Ziprasidone—CYP3A5—endocrine gland—obesity	7.92e-05	0.00288	CbGeAlD
Ziprasidone—Aripiprazole—SLC6A4—obesity	7.85e-05	0.0377	CrCbGaD
Ziprasidone—Trazodone—SLC6A4—obesity	7.81e-05	0.0375	CrCbGaD
Ziprasidone—Aripiprazole—DRD2—obesity	7.81e-05	0.0375	CrCbGaD
Ziprasidone—HTR2A—digestive system—obesity	7.77e-05	0.00282	CbGeAlD
Ziprasidone—HRH1—endocrine gland—obesity	7.69e-05	0.00279	CbGeAlD
Ziprasidone—ADRA2A—endocrine gland—obesity	7.55e-05	0.00274	CbGeAlD
Ziprasidone—HTR2A—adrenal gland—obesity	7.41e-05	0.00269	CbGeAlD
Ziprasidone—CYP1A2—liver—obesity	7.41e-05	0.00269	CbGeAlD
Ziprasidone—CYP3A4—digestive system—obesity	7.2e-05	0.00261	CbGeAlD
Ziprasidone—CYP3A5—liver—obesity	7.14e-05	0.0026	CbGeAlD
Ziprasidone—CYP2D6—digestive system—obesity	7.08e-05	0.00257	CbGeAlD
Ziprasidone—Clozapine—DRD4—obesity	7.03e-05	0.0337	CrCbGaD
Ziprasidone—HTR2A—endocrine gland—obesity	6.42e-05	0.00233	CbGeAlD
Ziprasidone—Clozapine—HTR1B—obesity	6.25e-05	0.03	CrCbGaD
Ziprasidone—Aripiprazole—HTR2A—obesity	6.03e-05	0.0289	CrCbGaD
Ziprasidone—Trazodone—HTR2A—obesity	6e-05	0.0288	CrCbGaD
Ziprasidone—Clozapine—DRD1—obesity	5.95e-05	0.0286	CrCbGaD
Ziprasidone—CYP3A4—endocrine gland—obesity	5.95e-05	0.00216	CbGeAlD
Ziprasidone—CYP2D6—endocrine gland—obesity	5.85e-05	0.00213	CbGeAlD
Ziprasidone—HTR2A—liver—obesity	5.79e-05	0.0021	CbGeAlD
Ziprasidone—CYP3A4—liver—obesity	5.36e-05	0.00195	CbGeAlD
Ziprasidone—CYP2D6—liver—obesity	5.28e-05	0.00192	CbGeAlD
Ziprasidone—Clozapine—HTR2C—obesity	5.09e-05	0.0244	CrCbGaD
Ziprasidone—Angioedema—Sibutramine—obesity	4.87e-05	0.000544	CcSEcCtD
Ziprasidone—Palpitations—Orlistat—obesity	4.86e-05	0.000544	CcSEcCtD
Ziprasidone—Angiopathy—Bupropion—obesity	4.84e-05	0.000541	CcSEcCtD
Ziprasidone—Nausea—Cimetidine—obesity	4.83e-05	0.000541	CcSEcCtD
Ziprasidone—Immune system disorder—Bupropion—obesity	4.82e-05	0.000539	CcSEcCtD
Ziprasidone—Mediastinal disorder—Bupropion—obesity	4.81e-05	0.000538	CcSEcCtD
Ziprasidone—Cough—Orlistat—obesity	4.8e-05	0.000537	CcSEcCtD
Ziprasidone—Psychotic disorder—Topiramate—obesity	4.8e-05	0.000537	CcSEcCtD
Ziprasidone—Chills—Bupropion—obesity	4.79e-05	0.000535	CcSEcCtD
Ziprasidone—Vertigo—Sibutramine—obesity	4.78e-05	0.000535	CcSEcCtD
Ziprasidone—Syncope—Sibutramine—obesity	4.78e-05	0.000534	CcSEcCtD
Ziprasidone—Leukopenia—Sibutramine—obesity	4.77e-05	0.000533	CcSEcCtD
Ziprasidone—Arrhythmia—Bupropion—obesity	4.76e-05	0.000533	CcSEcCtD
Ziprasidone—Face oedema—Topiramate—obesity	4.74e-05	0.00053	CcSEcCtD
Ziprasidone—Alopecia—Bupropion—obesity	4.71e-05	0.000527	CcSEcCtD
Ziprasidone—Palpitations—Sibutramine—obesity	4.71e-05	0.000527	CcSEcCtD
Ziprasidone—Myalgia—Orlistat—obesity	4.68e-05	0.000524	CcSEcCtD
Ziprasidone—Chest pain—Orlistat—obesity	4.68e-05	0.000524	CcSEcCtD
Ziprasidone—Loss of consciousness—Sibutramine—obesity	4.68e-05	0.000524	CcSEcCtD
Ziprasidone—Mental disorder—Bupropion—obesity	4.67e-05	0.000523	CcSEcCtD
Ziprasidone—Urinary retention—Topiramate—obesity	4.67e-05	0.000522	CcSEcCtD
Ziprasidone—Anxiety—Orlistat—obesity	4.67e-05	0.000522	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	4.65e-05	0.000521	CcSEcCtD
Ziprasidone—Cough—Sibutramine—obesity	4.65e-05	0.00052	CcSEcCtD
Ziprasidone—Malnutrition—Bupropion—obesity	4.64e-05	0.000519	CcSEcCtD
Ziprasidone—Ataxia—Topiramate—obesity	4.62e-05	0.000517	CcSEcCtD
Ziprasidone—Blood creatinine increased—Topiramate—obesity	4.6e-05	0.000515	CcSEcCtD
Ziprasidone—Hypertension—Sibutramine—obesity	4.6e-05	0.000514	CcSEcCtD
Ziprasidone—Dry mouth—Orlistat—obesity	4.58e-05	0.000513	CcSEcCtD
Ziprasidone—Flatulence—Bupropion—obesity	4.57e-05	0.000512	CcSEcCtD
Ziprasidone—Dehydration—Topiramate—obesity	4.57e-05	0.000511	CcSEcCtD
Ziprasidone—Liver function test abnormal—Topiramate—obesity	4.53e-05	0.000507	CcSEcCtD
Ziprasidone—Chest pain—Sibutramine—obesity	4.53e-05	0.000507	CcSEcCtD
Ziprasidone—Myalgia—Sibutramine—obesity	4.53e-05	0.000507	CcSEcCtD
Ziprasidone—Arthralgia—Sibutramine—obesity	4.53e-05	0.000507	CcSEcCtD
Ziprasidone—Anxiety—Sibutramine—obesity	4.52e-05	0.000505	CcSEcCtD
Ziprasidone—Back pain—Bupropion—obesity	4.49e-05	0.000502	CcSEcCtD
Ziprasidone—Orthostatic hypotension—Topiramate—obesity	4.49e-05	0.000502	CcSEcCtD
Ziprasidone—Hypokalaemia—Topiramate—obesity	4.47e-05	0.0005	CcSEcCtD
Ziprasidone—Muscle spasms—Bupropion—obesity	4.46e-05	0.000499	CcSEcCtD
Ziprasidone—Infection—Orlistat—obesity	4.46e-05	0.000499	CcSEcCtD
Ziprasidone—Breast disorder—Topiramate—obesity	4.44e-05	0.000497	CcSEcCtD
Ziprasidone—Dry mouth—Sibutramine—obesity	4.43e-05	0.000496	CcSEcCtD
Ziprasidone—Nervous system disorder—Orlistat—obesity	4.4e-05	0.000493	CcSEcCtD
Ziprasidone—Nasopharyngitis—Topiramate—obesity	4.39e-05	0.000491	CcSEcCtD
Ziprasidone—Confusional state—Sibutramine—obesity	4.38e-05	0.00049	CcSEcCtD
Ziprasidone—Vision blurred—Bupropion—obesity	4.38e-05	0.00049	CcSEcCtD
Ziprasidone—Skin disorder—Orlistat—obesity	4.36e-05	0.000488	CcSEcCtD
Ziprasidone—Tremor—Bupropion—obesity	4.35e-05	0.000487	CcSEcCtD
Ziprasidone—Gastritis—Topiramate—obesity	4.35e-05	0.000486	CcSEcCtD
Ziprasidone—Hyperhidrosis—Orlistat—obesity	4.34e-05	0.000486	CcSEcCtD
Ziprasidone—Infection—Sibutramine—obesity	4.32e-05	0.000483	CcSEcCtD
Ziprasidone—Anaemia—Bupropion—obesity	4.29e-05	0.00048	CcSEcCtD
Ziprasidone—Shock—Sibutramine—obesity	4.28e-05	0.000478	CcSEcCtD
Ziprasidone—Agitation—Bupropion—obesity	4.27e-05	0.000477	CcSEcCtD
Ziprasidone—Thrombocytopenia—Sibutramine—obesity	4.26e-05	0.000476	CcSEcCtD
Ziprasidone—Dysphagia—Topiramate—obesity	4.24e-05	0.000475	CcSEcCtD
Ziprasidone—Angioedema—Bupropion—obesity	4.24e-05	0.000475	CcSEcCtD
Ziprasidone—Tachycardia—Sibutramine—obesity	4.24e-05	0.000475	CcSEcCtD
Ziprasidone—Skin disorder—Sibutramine—obesity	4.22e-05	0.000472	CcSEcCtD
Ziprasidone—Eosinophilia—Topiramate—obesity	4.2e-05	0.00047	CcSEcCtD
Ziprasidone—Hyperhidrosis—Sibutramine—obesity	4.2e-05	0.00047	CcSEcCtD
Ziprasidone—Clozapine—DRD2—obesity	4.2e-05	0.0201	CrCbGaD
Ziprasidone—Vertigo—Bupropion—obesity	4.17e-05	0.000467	CcSEcCtD
Ziprasidone—Syncope—Bupropion—obesity	4.16e-05	0.000466	CcSEcCtD
Ziprasidone—Leukopenia—Bupropion—obesity	4.16e-05	0.000465	CcSEcCtD
Ziprasidone—Anorexia—Sibutramine—obesity	4.14e-05	0.000463	CcSEcCtD
Ziprasidone—Sweating increased—Topiramate—obesity	4.14e-05	0.000463	CcSEcCtD
Ziprasidone—Angina pectoris—Topiramate—obesity	4.14e-05	0.000463	CcSEcCtD
Ziprasidone—Palpitations—Bupropion—obesity	4.1e-05	0.000459	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Orlistat—obesity	4.09e-05	0.000458	CcSEcCtD
Ziprasidone—Loss of consciousness—Bupropion—obesity	4.08e-05	0.000457	CcSEcCtD
Ziprasidone—Abdominal discomfort—Topiramate—obesity	4.07e-05	0.000455	CcSEcCtD
Ziprasidone—Insomnia—Orlistat—obesity	4.06e-05	0.000454	CcSEcCtD
Ziprasidone—Hypotension—Sibutramine—obesity	4.06e-05	0.000454	CcSEcCtD
Ziprasidone—Cough—Bupropion—obesity	4.05e-05	0.000453	CcSEcCtD
Ziprasidone—Clozapine—CYP2E1—obesity	4.04e-05	0.0194	CrCbGaD
Ziprasidone—Paraesthesia—Orlistat—obesity	4.03e-05	0.000451	CcSEcCtD
Ziprasidone—Hypertension—Bupropion—obesity	4.01e-05	0.000448	CcSEcCtD
Ziprasidone—Dysuria—Topiramate—obesity	3.97e-05	0.000444	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Sibutramine—obesity	3.96e-05	0.000443	CcSEcCtD
Ziprasidone—Dyspepsia—Orlistat—obesity	3.95e-05	0.000442	CcSEcCtD
Ziprasidone—Chest pain—Bupropion—obesity	3.95e-05	0.000442	CcSEcCtD
Ziprasidone—Arthralgia—Bupropion—obesity	3.95e-05	0.000442	CcSEcCtD
Ziprasidone—Myalgia—Bupropion—obesity	3.95e-05	0.000442	CcSEcCtD
Ziprasidone—Upper respiratory tract infection—Topiramate—obesity	3.95e-05	0.000441	CcSEcCtD
Ziprasidone—Anxiety—Bupropion—obesity	3.94e-05	0.000441	CcSEcCtD
Ziprasidone—Insomnia—Sibutramine—obesity	3.93e-05	0.00044	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	3.93e-05	0.000439	CcSEcCtD
Ziprasidone—Erectile dysfunction—Topiramate—obesity	3.91e-05	0.000437	CcSEcCtD
Ziprasidone—Decreased appetite—Orlistat—obesity	3.9e-05	0.000437	CcSEcCtD
Ziprasidone—Paraesthesia—Sibutramine—obesity	3.9e-05	0.000437	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Orlistat—obesity	3.88e-05	0.000434	CcSEcCtD
Ziprasidone—Dyspnoea—Sibutramine—obesity	3.87e-05	0.000434	CcSEcCtD
Ziprasidone—Photosensitivity reaction—Topiramate—obesity	3.87e-05	0.000433	CcSEcCtD
Ziprasidone—Fatigue—Orlistat—obesity	3.87e-05	0.000433	CcSEcCtD
Ziprasidone—Dry mouth—Bupropion—obesity	3.87e-05	0.000432	CcSEcCtD
Ziprasidone—Somnolence—Sibutramine—obesity	3.86e-05	0.000432	CcSEcCtD
Ziprasidone—Weight increased—Topiramate—obesity	3.86e-05	0.000432	CcSEcCtD
Ziprasidone—Weight decreased—Topiramate—obesity	3.84e-05	0.00043	CcSEcCtD
Ziprasidone—Hyperglycaemia—Topiramate—obesity	3.83e-05	0.000428	CcSEcCtD
Ziprasidone—Dyspepsia—Sibutramine—obesity	3.83e-05	0.000428	CcSEcCtD
Ziprasidone—Confusional state—Bupropion—obesity	3.82e-05	0.000427	CcSEcCtD
Ziprasidone—Pneumonia—Topiramate—obesity	3.81e-05	0.000426	CcSEcCtD
Ziprasidone—Infestation NOS—Topiramate—obesity	3.78e-05	0.000423	CcSEcCtD
Ziprasidone—Infestation—Topiramate—obesity	3.78e-05	0.000423	CcSEcCtD
Ziprasidone—Decreased appetite—Sibutramine—obesity	3.78e-05	0.000423	CcSEcCtD
Ziprasidone—Infection—Bupropion—obesity	3.76e-05	0.000421	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Sibutramine—obesity	3.75e-05	0.00042	CcSEcCtD
Ziprasidone—Shock—Bupropion—obesity	3.73e-05	0.000417	CcSEcCtD
Ziprasidone—Renal failure—Topiramate—obesity	3.72e-05	0.000416	CcSEcCtD
Ziprasidone—Constipation—Sibutramine—obesity	3.72e-05	0.000416	CcSEcCtD
Ziprasidone—Nervous system disorder—Bupropion—obesity	3.72e-05	0.000416	CcSEcCtD
Ziprasidone—Neuropathy peripheral—Topiramate—obesity	3.71e-05	0.000415	CcSEcCtD
Ziprasidone—Thrombocytopenia—Bupropion—obesity	3.71e-05	0.000415	CcSEcCtD
Ziprasidone—Feeling abnormal—Orlistat—obesity	3.7e-05	0.000414	CcSEcCtD
Ziprasidone—Tachycardia—Bupropion—obesity	3.7e-05	0.000414	CcSEcCtD
Ziprasidone—Skin disorder—Bupropion—obesity	3.68e-05	0.000412	CcSEcCtD
Ziprasidone—Conjunctivitis—Topiramate—obesity	3.68e-05	0.000412	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Orlistat—obesity	3.67e-05	0.000411	CcSEcCtD
Ziprasidone—Hyperhidrosis—Bupropion—obesity	3.66e-05	0.00041	CcSEcCtD
Ziprasidone—Anorexia—Bupropion—obesity	3.61e-05	0.000404	CcSEcCtD
Ziprasidone—Haematuria—Topiramate—obesity	3.61e-05	0.000404	CcSEcCtD
Ziprasidone—Feeling abnormal—Sibutramine—obesity	3.58e-05	0.000401	CcSEcCtD
Ziprasidone—Epistaxis—Topiramate—obesity	3.57e-05	0.000399	CcSEcCtD
Ziprasidone—Urticaria—Orlistat—obesity	3.57e-05	0.000399	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Sibutramine—obesity	3.55e-05	0.000398	CcSEcCtD
Ziprasidone—Abdominal pain—Orlistat—obesity	3.55e-05	0.000397	CcSEcCtD
Ziprasidone—Body temperature increased—Orlistat—obesity	3.55e-05	0.000397	CcSEcCtD
Ziprasidone—Hypotension—Bupropion—obesity	3.54e-05	0.000396	CcSEcCtD
Ziprasidone—Bradycardia—Topiramate—obesity	3.46e-05	0.000387	CcSEcCtD
Ziprasidone—Urticaria—Sibutramine—obesity	3.45e-05	0.000386	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Bupropion—obesity	3.45e-05	0.000386	CcSEcCtD
Ziprasidone—Body temperature increased—Sibutramine—obesity	3.44e-05	0.000384	CcSEcCtD
Ziprasidone—Abdominal pain—Sibutramine—obesity	3.44e-05	0.000384	CcSEcCtD
Ziprasidone—Insomnia—Bupropion—obesity	3.43e-05	0.000383	CcSEcCtD
Ziprasidone—Haemoglobin—Topiramate—obesity	3.42e-05	0.000382	CcSEcCtD
Ziprasidone—Rhinitis—Topiramate—obesity	3.41e-05	0.000381	CcSEcCtD
Ziprasidone—Paraesthesia—Bupropion—obesity	3.4e-05	0.000381	CcSEcCtD
Ziprasidone—Hepatitis—Topiramate—obesity	3.4e-05	0.00038	CcSEcCtD
Ziprasidone—Haemorrhage—Topiramate—obesity	3.4e-05	0.00038	CcSEcCtD
Ziprasidone—Hypoaesthesia—Topiramate—obesity	3.38e-05	0.000378	CcSEcCtD
Ziprasidone—Dyspnoea—Bupropion—obesity	3.38e-05	0.000378	CcSEcCtD
Ziprasidone—Pharyngitis—Topiramate—obesity	3.37e-05	0.000377	CcSEcCtD
Ziprasidone—Somnolence—Bupropion—obesity	3.37e-05	0.000377	CcSEcCtD
Ziprasidone—Urinary tract disorder—Topiramate—obesity	3.36e-05	0.000375	CcSEcCtD
Ziprasidone—Oedema peripheral—Topiramate—obesity	3.35e-05	0.000374	CcSEcCtD
Ziprasidone—Connective tissue disorder—Topiramate—obesity	3.34e-05	0.000374	CcSEcCtD
Ziprasidone—Dyspepsia—Bupropion—obesity	3.34e-05	0.000373	CcSEcCtD
Ziprasidone—Urethral disorder—Topiramate—obesity	3.33e-05	0.000373	CcSEcCtD
Ziprasidone—Hypersensitivity—Orlistat—obesity	3.31e-05	0.00037	CcSEcCtD
Ziprasidone—Decreased appetite—Bupropion—obesity	3.29e-05	0.000368	CcSEcCtD
Ziprasidone—Visual impairment—Topiramate—obesity	3.27e-05	0.000366	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Bupropion—obesity	3.27e-05	0.000366	CcSEcCtD
Ziprasidone—Fatigue—Bupropion—obesity	3.27e-05	0.000365	CcSEcCtD
Ziprasidone—Clozapine—HTR2A—obesity	3.24e-05	0.0156	CrCbGaD
Ziprasidone—Constipation—Bupropion—obesity	3.24e-05	0.000362	CcSEcCtD
Ziprasidone—Asthenia—Orlistat—obesity	3.22e-05	0.00036	CcSEcCtD
Ziprasidone—Hypersensitivity—Sibutramine—obesity	3.2e-05	0.000358	CcSEcCtD
Ziprasidone—Eye disorder—Topiramate—obesity	3.18e-05	0.000355	CcSEcCtD
Ziprasidone—Tinnitus—Topiramate—obesity	3.17e-05	0.000354	CcSEcCtD
Ziprasidone—Cardiac disorder—Topiramate—obesity	3.15e-05	0.000353	CcSEcCtD
Ziprasidone—Feeling abnormal—Bupropion—obesity	3.12e-05	0.000349	CcSEcCtD
Ziprasidone—Asthenia—Sibutramine—obesity	3.12e-05	0.000349	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Bupropion—obesity	3.1e-05	0.000347	CcSEcCtD
Ziprasidone—Angiopathy—Topiramate—obesity	3.08e-05	0.000345	CcSEcCtD
Ziprasidone—Diarrhoea—Orlistat—obesity	3.07e-05	0.000344	CcSEcCtD
Ziprasidone—Immune system disorder—Topiramate—obesity	3.07e-05	0.000343	CcSEcCtD
Ziprasidone—Mediastinal disorder—Topiramate—obesity	3.06e-05	0.000343	CcSEcCtD
Ziprasidone—Chills—Topiramate—obesity	3.05e-05	0.000341	CcSEcCtD
Ziprasidone—Urticaria—Bupropion—obesity	3.01e-05	0.000337	CcSEcCtD
Ziprasidone—Alopecia—Topiramate—obesity	3e-05	0.000336	CcSEcCtD
Ziprasidone—Abdominal pain—Bupropion—obesity	3e-05	0.000335	CcSEcCtD
Ziprasidone—Body temperature increased—Bupropion—obesity	3e-05	0.000335	CcSEcCtD
Ziprasidone—Mental disorder—Topiramate—obesity	2.98e-05	0.000333	CcSEcCtD
Ziprasidone—Diarrhoea—Sibutramine—obesity	2.97e-05	0.000333	CcSEcCtD
Ziprasidone—Dizziness—Orlistat—obesity	2.97e-05	0.000332	CcSEcCtD
Ziprasidone—Erythema—Topiramate—obesity	2.96e-05	0.000331	CcSEcCtD
Ziprasidone—Malnutrition—Topiramate—obesity	2.96e-05	0.000331	CcSEcCtD
Ziprasidone—Flatulence—Topiramate—obesity	2.91e-05	0.000326	CcSEcCtD
Ziprasidone—Dizziness—Sibutramine—obesity	2.87e-05	0.000322	CcSEcCtD
Ziprasidone—Back pain—Topiramate—obesity	2.86e-05	0.00032	CcSEcCtD
Ziprasidone—Vomiting—Orlistat—obesity	2.86e-05	0.000319	CcSEcCtD
Ziprasidone—Muscle spasms—Topiramate—obesity	2.84e-05	0.000318	CcSEcCtD
Ziprasidone—Rash—Orlistat—obesity	2.83e-05	0.000317	CcSEcCtD
Ziprasidone—Dermatitis—Orlistat—obesity	2.83e-05	0.000316	CcSEcCtD
Ziprasidone—Headache—Orlistat—obesity	2.81e-05	0.000315	CcSEcCtD
Ziprasidone—Hypersensitivity—Bupropion—obesity	2.79e-05	0.000312	CcSEcCtD
Ziprasidone—Vision blurred—Topiramate—obesity	2.79e-05	0.000312	CcSEcCtD
Ziprasidone—Tremor—Topiramate—obesity	2.77e-05	0.00031	CcSEcCtD
Ziprasidone—Vomiting—Sibutramine—obesity	2.76e-05	0.000309	CcSEcCtD
Ziprasidone—Rash—Sibutramine—obesity	2.74e-05	0.000307	CcSEcCtD
Ziprasidone—Dermatitis—Sibutramine—obesity	2.74e-05	0.000306	CcSEcCtD
Ziprasidone—Anaemia—Topiramate—obesity	2.73e-05	0.000306	CcSEcCtD
Ziprasidone—Headache—Sibutramine—obesity	2.72e-05	0.000305	CcSEcCtD
Ziprasidone—Asthenia—Bupropion—obesity	2.72e-05	0.000304	CcSEcCtD
Ziprasidone—Agitation—Topiramate—obesity	2.72e-05	0.000304	CcSEcCtD
Ziprasidone—Nausea—Orlistat—obesity	2.67e-05	0.000298	CcSEcCtD
Ziprasidone—Vertigo—Topiramate—obesity	2.66e-05	0.000297	CcSEcCtD
Ziprasidone—Syncope—Topiramate—obesity	2.65e-05	0.000297	CcSEcCtD
Ziprasidone—Leukopenia—Topiramate—obesity	2.65e-05	0.000296	CcSEcCtD
Ziprasidone—Palpitations—Topiramate—obesity	2.61e-05	0.000292	CcSEcCtD
Ziprasidone—Loss of consciousness—Topiramate—obesity	2.6e-05	0.000291	CcSEcCtD
Ziprasidone—Diarrhoea—Bupropion—obesity	2.59e-05	0.00029	CcSEcCtD
Ziprasidone—Nausea—Sibutramine—obesity	2.58e-05	0.000289	CcSEcCtD
Ziprasidone—Cough—Topiramate—obesity	2.58e-05	0.000289	CcSEcCtD
Ziprasidone—Hypertension—Topiramate—obesity	2.55e-05	0.000286	CcSEcCtD
Ziprasidone—Myalgia—Topiramate—obesity	2.52e-05	0.000282	CcSEcCtD
Ziprasidone—Chest pain—Topiramate—obesity	2.52e-05	0.000282	CcSEcCtD
Ziprasidone—Arthralgia—Topiramate—obesity	2.52e-05	0.000282	CcSEcCtD
Ziprasidone—Anxiety—Topiramate—obesity	2.51e-05	0.000281	CcSEcCtD
Ziprasidone—Dizziness—Bupropion—obesity	2.51e-05	0.00028	CcSEcCtD
Ziprasidone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	2.5e-05	0.00028	CcSEcCtD
Ziprasidone—Dry mouth—Topiramate—obesity	2.46e-05	0.000276	CcSEcCtD
Ziprasidone—Confusional state—Topiramate—obesity	2.43e-05	0.000272	CcSEcCtD
Ziprasidone—Vomiting—Bupropion—obesity	2.41e-05	0.00027	CcSEcCtD
Ziprasidone—Infection—Topiramate—obesity	2.4e-05	0.000268	CcSEcCtD
Ziprasidone—Rash—Bupropion—obesity	2.39e-05	0.000267	CcSEcCtD
Ziprasidone—Dermatitis—Bupropion—obesity	2.39e-05	0.000267	CcSEcCtD
Ziprasidone—Shock—Topiramate—obesity	2.37e-05	0.000266	CcSEcCtD
Ziprasidone—Headache—Bupropion—obesity	2.37e-05	0.000266	CcSEcCtD
Ziprasidone—Nervous system disorder—Topiramate—obesity	2.37e-05	0.000265	CcSEcCtD
Ziprasidone—Thrombocytopenia—Topiramate—obesity	2.36e-05	0.000264	CcSEcCtD
Ziprasidone—Tachycardia—Topiramate—obesity	2.36e-05	0.000264	CcSEcCtD
Ziprasidone—Skin disorder—Topiramate—obesity	2.34e-05	0.000262	CcSEcCtD
Ziprasidone—Hyperhidrosis—Topiramate—obesity	2.33e-05	0.000261	CcSEcCtD
Ziprasidone—Anorexia—Topiramate—obesity	2.3e-05	0.000257	CcSEcCtD
Ziprasidone—Hypotension—Topiramate—obesity	2.26e-05	0.000252	CcSEcCtD
Ziprasidone—Nausea—Bupropion—obesity	2.25e-05	0.000252	CcSEcCtD
Ziprasidone—Musculoskeletal discomfort—Topiramate—obesity	2.2e-05	0.000246	CcSEcCtD
Ziprasidone—Insomnia—Topiramate—obesity	2.18e-05	0.000244	CcSEcCtD
Ziprasidone—Paraesthesia—Topiramate—obesity	2.17e-05	0.000243	CcSEcCtD
Ziprasidone—Dyspnoea—Topiramate—obesity	2.15e-05	0.000241	CcSEcCtD
Ziprasidone—Somnolence—Topiramate—obesity	2.15e-05	0.00024	CcSEcCtD
Ziprasidone—Dyspepsia—Topiramate—obesity	2.12e-05	0.000238	CcSEcCtD
Ziprasidone—Decreased appetite—Topiramate—obesity	2.1e-05	0.000235	CcSEcCtD
Ziprasidone—Gastrointestinal disorder—Topiramate—obesity	2.08e-05	0.000233	CcSEcCtD
Ziprasidone—Fatigue—Topiramate—obesity	2.08e-05	0.000233	CcSEcCtD
Ziprasidone—Constipation—Topiramate—obesity	2.06e-05	0.000231	CcSEcCtD
Ziprasidone—Feeling abnormal—Topiramate—obesity	1.99e-05	0.000223	CcSEcCtD
Ziprasidone—Gastrointestinal pain—Topiramate—obesity	1.97e-05	0.000221	CcSEcCtD
Ziprasidone—Urticaria—Topiramate—obesity	1.92e-05	0.000215	CcSEcCtD
Ziprasidone—Body temperature increased—Topiramate—obesity	1.91e-05	0.000213	CcSEcCtD
Ziprasidone—Abdominal pain—Topiramate—obesity	1.91e-05	0.000213	CcSEcCtD
Ziprasidone—Hypersensitivity—Topiramate—obesity	1.78e-05	0.000199	CcSEcCtD
Ziprasidone—Asthenia—Topiramate—obesity	1.73e-05	0.000194	CcSEcCtD
Ziprasidone—Diarrhoea—Topiramate—obesity	1.65e-05	0.000185	CcSEcCtD
Ziprasidone—Dizziness—Topiramate—obesity	1.6e-05	0.000179	CcSEcCtD
Ziprasidone—Vomiting—Topiramate—obesity	1.53e-05	0.000172	CcSEcCtD
Ziprasidone—Rash—Topiramate—obesity	1.52e-05	0.00017	CcSEcCtD
Ziprasidone—Dermatitis—Topiramate—obesity	1.52e-05	0.00017	CcSEcCtD
Ziprasidone—Headache—Topiramate—obesity	1.51e-05	0.000169	CcSEcCtD
Ziprasidone—Nausea—Topiramate—obesity	1.43e-05	0.00016	CcSEcCtD
Ziprasidone—HRH1—Signaling Pathways—PIK3CB—obesity	4.12e-07	5.22e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PIK3CB—obesity	4.11e-07	5.22e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—RHOA—obesity	4.11e-07	5.21e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—PIK3CB—obesity	4.1e-07	5.21e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MTOR—obesity	4.1e-07	5.21e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—PIK3CB—obesity	4.09e-07	5.19e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MTOR—obesity	4.09e-07	5.19e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—obesity	4.08e-07	5.17e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GOT1—obesity	4.07e-07	5.17e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GGT1—obesity	4.07e-07	5.17e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PIK3R1—obesity	4.07e-07	5.16e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—NOS3—obesity	4.07e-07	5.16e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CD36—obesity	4.06e-07	5.15e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—PIK3CB—obesity	4.05e-07	5.14e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MTOR—obesity	4.05e-07	5.14e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—PIK3CB—obesity	4.04e-07	5.12e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MTOR—obesity	4.04e-07	5.12e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MAPK8—obesity	4.04e-07	5.12e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—AKT1—obesity	4.03e-07	5.11e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MMP9—obesity	4.02e-07	5.1e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MAPK8—obesity	4.02e-07	5.09e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NCOA1—obesity	4.01e-07	5.09e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—AKT1—obesity	4.01e-07	5.08e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—MYC—obesity	3.99e-07	5.06e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TGFB1—obesity	3.98e-07	5.05e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MMP9—obesity	3.95e-07	5.01e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CYP19A1—obesity	3.95e-07	5.01e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—STK11—obesity	3.95e-07	5.01e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—MYC—obesity	3.94e-07	4.99e-06	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—PIK3CA—obesity	3.93e-07	4.99e-06	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—PIK3CA—obesity	3.93e-07	4.98e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TGFB1—obesity	3.93e-07	4.98e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MAPK8—obesity	3.91e-07	4.96e-06	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—PIK3CA—obesity	3.9e-07	4.95e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—AKT1—obesity	3.9e-07	4.94e-06	CbGpPWpGaD
Ziprasidone—DRD2—GPCR downstream signaling—AKT1—obesity	3.89e-07	4.94e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—PIK3CA—obesity	3.87e-07	4.91e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—MTHFR—obesity	3.85e-07	4.88e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MAPK8—obesity	3.84e-07	4.88e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—AKT1—obesity	3.83e-07	4.86e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—IL6—obesity	3.83e-07	4.86e-06	CbGpPWpGaD
Ziprasidone—HTR2A—GPCR downstream signaling—AKT1—obesity	3.83e-07	4.86e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—STAT3—obesity	3.82e-07	4.85e-06	CbGpPWpGaD
Ziprasidone—HRH1—GPCR downstream signaling—AKT1—obesity	3.82e-07	4.85e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—PIK3CA—obesity	3.82e-07	4.85e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PIK3CG—obesity	3.82e-07	4.84e-06	CbGpPWpGaD
Ziprasidone—CHRM1—GPCR downstream signaling—AKT1—obesity	3.81e-07	4.83e-06	CbGpPWpGaD
Ziprasidone—CHRM3—GPCR downstream signaling—AKT1—obesity	3.8e-07	4.82e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARA—obesity	3.78e-07	4.79e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—IL6—obesity	3.77e-07	4.78e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—IL6—obesity	3.76e-07	4.77e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—PIK3CA—obesity	3.76e-07	4.77e-06	CbGpPWpGaD
Ziprasidone—CHRM2—GPCR downstream signaling—AKT1—obesity	3.76e-07	4.77e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PIK3CB—obesity	3.75e-07	4.76e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MTOR—obesity	3.75e-07	4.76e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—GPCR downstream signaling—AKT1—obesity	3.75e-07	4.76e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—IL6—obesity	3.75e-07	4.76e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—IL6—obesity	3.74e-07	4.74e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—PIK3CA—obesity	3.71e-07	4.71e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—IL6—obesity	3.7e-07	4.7e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—IL6—obesity	3.69e-07	4.68e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—STAT3—obesity	3.69e-07	4.68e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PPARG—obesity	3.68e-07	4.67e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—COMT—obesity	3.68e-07	4.66e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—STAT3—obesity	3.67e-07	4.66e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AGT—obesity	3.66e-07	4.64e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MMP9—obesity	3.64e-07	4.62e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—POMC—obesity	3.63e-07	4.61e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARGC1A—obesity	3.62e-07	4.6e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GNB3—obesity	3.62e-07	4.6e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—INS—obesity	3.61e-07	4.58e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—HMOX1—obesity	3.61e-07	4.58e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MMP9—obesity	3.59e-07	4.55e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOE—obesity	3.58e-07	4.55e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MMP9—obesity	3.58e-07	4.54e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—STAT3—obesity	3.57e-07	4.53e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MMP9—obesity	3.57e-07	4.52e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MMP9—obesity	3.56e-07	4.51e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—PIK3CA—obesity	3.55e-07	4.51e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—MYC—obesity	3.55e-07	4.51e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—CAV1—obesity	3.55e-07	4.5e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MAPK8—obesity	3.54e-07	4.5e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TGFB1—obesity	3.54e-07	4.5e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—APOA1—obesity	3.54e-07	4.49e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—AKT1—obesity	3.53e-07	4.48e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GNAS—obesity	3.53e-07	4.48e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MMP9—obesity	3.52e-07	4.47e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—STAT3—obesity	3.51e-07	4.46e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MMP9—obesity	3.51e-07	4.45e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MAPK8—obesity	3.49e-07	4.42e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—GPCR downstream signaling—AKT1—obesity	3.48e-07	4.42e-06	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—IL6—obesity	3.48e-07	4.42e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MAPK8—obesity	3.48e-07	4.41e-06	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—IL6—obesity	3.48e-07	4.41e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—AKT1—obesity	3.48e-07	4.41e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—AKT1—obesity	3.47e-07	4.4e-06	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—PIK3CA—obesity	3.47e-07	4.4e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MAPK8—obesity	3.47e-07	4.4e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—AKT1—obesity	3.46e-07	4.39e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MAPK8—obesity	3.46e-07	4.39e-06	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—IL6—obesity	3.46e-07	4.38e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOB—obesity	3.46e-07	4.38e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—AKT1—obesity	3.45e-07	4.37e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—IL6—obesity	3.43e-07	4.35e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—MYC—obesity	3.43e-07	4.35e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MAPK8—obesity	3.42e-07	4.34e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TGFB1—obesity	3.42e-07	4.34e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—AKT1—obesity	3.42e-07	4.33e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MAPK8—obesity	3.42e-07	4.33e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—MYC—obesity	3.41e-07	4.33e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—AKT1—obesity	3.41e-07	4.32e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TGFB1—obesity	3.4e-07	4.32e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.39e-07	4.3e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—PIK3CA—obesity	3.39e-07	4.29e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—IL6—obesity	3.38e-07	4.29e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—PIK3CA—obesity	3.37e-07	4.27e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PIK3CD—obesity	3.36e-07	4.26e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—PIK3CA—obesity	3.34e-07	4.24e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—IL6—obesity	3.33e-07	4.22e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—MYC—obesity	3.32e-07	4.21e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ALB—obesity	3.31e-07	4.2e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TGFB1—obesity	3.31e-07	4.2e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—LPL—obesity	3.3e-07	4.19e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—IL6—obesity	3.29e-07	4.17e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—MYC—obesity	3.27e-07	4.14e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MMP9—obesity	3.26e-07	4.14e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TGFB1—obesity	3.26e-07	4.13e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—STAT3—obesity	3.24e-07	4.11e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PIK3CG—obesity	3.23e-07	4.1e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GPX1—obesity	3.22e-07	4.08e-06	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—AKT1—obesity	3.21e-07	4.08e-06	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—AKT1—obesity	3.21e-07	4.07e-06	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—AKT1—obesity	3.19e-07	4.04e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—STAT3—obesity	3.19e-07	4.04e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—STAT3—obesity	3.18e-07	4.04e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MAPK8—obesity	3.17e-07	4.02e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—STAT3—obesity	3.17e-07	4.02e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—NOS3—obesity	3.17e-07	4.02e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PIK3R1—obesity	3.17e-07	4.02e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—AKT1—obesity	3.16e-07	4.01e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—STAT3—obesity	3.16e-07	4.01e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—IL6—obesity	3.15e-07	3.99e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CD36—obesity	3.13e-07	3.98e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—STAT3—obesity	3.13e-07	3.97e-06	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—AKT1—obesity	3.12e-07	3.96e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—STAT3—obesity	3.12e-07	3.96e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PPARG—obesity	3.12e-07	3.96e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—POMC—obesity	3.08e-07	3.9e-06	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—AKT1—obesity	3.07e-07	3.9e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—INS—obesity	3.06e-07	3.88e-06	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—AKT1—obesity	3.03e-07	3.84e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—PIK3CA—obesity	3.02e-07	3.83e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—MYC—obesity	3.01e-07	3.82e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TGFB1—obesity	3e-07	3.81e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—IL6—obesity	3e-07	3.8e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PIK3CA—obesity	2.98e-07	3.78e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MTHFR—obesity	2.97e-07	3.77e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—MYC—obesity	2.96e-07	3.76e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—IL6—obesity	2.96e-07	3.75e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—MYC—obesity	2.96e-07	3.75e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TGFB1—obesity	2.96e-07	3.75e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TGFB1—obesity	2.95e-07	3.74e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—MYC—obesity	2.95e-07	3.74e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TGFB1—obesity	2.94e-07	3.73e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—MYC—obesity	2.94e-07	3.73e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TGFB1—obesity	2.93e-07	3.72e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PIK3CB—obesity	2.93e-07	3.71e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARA—obesity	2.91e-07	3.7e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—PIK3CA—obesity	2.91e-07	3.69e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—MYC—obesity	2.91e-07	3.69e-06	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—AKT1—obesity	2.9e-07	3.68e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TGFB1—obesity	2.9e-07	3.68e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—MYC—obesity	2.9e-07	3.68e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—STAT3—obesity	2.9e-07	3.68e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—obesity	2.9e-07	3.68e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—PIK3CA—obesity	2.9e-07	3.67e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TGFB1—obesity	2.89e-07	3.67e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PIK3CD—obesity	2.84e-07	3.61e-06	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—AKT1—obesity	2.83e-07	3.59e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AGT—obesity	2.82e-07	3.58e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—PIK3CA—obesity	2.82e-07	3.57e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ALB—obesity	2.81e-07	3.56e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—PIK3CA—obesity	2.77e-07	3.52e-06	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—AKT1—obesity	2.77e-07	3.51e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOE—obesity	2.77e-07	3.51e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—AKT1—obesity	2.75e-07	3.49e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—CAV1—obesity	2.74e-07	3.48e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PIK3CA—obesity	2.74e-07	3.47e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—APOA1—obesity	2.73e-07	3.47e-06	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—AKT1—obesity	2.73e-07	3.46e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—MYC—obesity	2.7e-07	3.42e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TGFB1—obesity	2.69e-07	3.41e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—NOS3—obesity	2.68e-07	3.41e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PIK3R1—obesity	2.68e-07	3.41e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—IL6—obesity	2.67e-07	3.39e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—IL6—obesity	2.58e-07	3.27e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—IL6—obesity	2.56e-07	3.25e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—PIK3CA—obesity	2.56e-07	3.24e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—PIK3CA—obesity	2.52e-07	3.19e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—PIK3CA—obesity	2.51e-07	3.18e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PIK3CA—obesity	2.51e-07	3.18e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—PIK3CA—obesity	2.5e-07	3.17e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PIK3CG—obesity	2.5e-07	3.17e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IL6—obesity	2.49e-07	3.16e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—PIK3CA—obesity	2.49e-07	3.16e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PIK3CB—obesity	2.48e-07	3.14e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—PIK3CA—obesity	2.47e-07	3.13e-06	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—AKT1—obesity	2.46e-07	3.13e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.46e-07	3.12e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—obesity	2.46e-07	3.11e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IL6—obesity	2.46e-07	3.11e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—AKT1—obesity	2.44e-07	3.09e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PPARG—obesity	2.41e-07	3.06e-06	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—AKT1—obesity	2.38e-07	3.02e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—POMC—obesity	2.38e-07	3.01e-06	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—AKT1—obesity	2.37e-07	3e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—INS—obesity	2.36e-07	3e-06	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—AKT1—obesity	2.3e-07	2.92e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PIK3CA—obesity	2.29e-07	2.9e-06	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—AKT1—obesity	2.27e-07	2.87e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IL6—obesity	2.26e-07	2.87e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—AKT1—obesity	2.24e-07	2.84e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IL6—obesity	2.23e-07	2.83e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IL6—obesity	2.22e-07	2.82e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IL6—obesity	2.22e-07	2.81e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IL6—obesity	2.21e-07	2.8e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PIK3CD—obesity	2.19e-07	2.78e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IL6—obesity	2.19e-07	2.77e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IL6—obesity	2.18e-07	2.77e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ALB—obesity	2.17e-07	2.75e-06	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—AKT1—obesity	2.09e-07	2.65e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PIK3R1—obesity	2.07e-07	2.63e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—NOS3—obesity	2.07e-07	2.63e-06	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—AKT1—obesity	2.05e-07	2.61e-06	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—AKT1—obesity	2.05e-07	2.6e-06	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—AKT1—obesity	2.05e-07	2.6e-06	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—AKT1—obesity	2.04e-07	2.59e-06	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—AKT1—obesity	2.04e-07	2.58e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IL6—obesity	2.03e-07	2.57e-06	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—AKT1—obesity	2.02e-07	2.56e-06	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—AKT1—obesity	2.01e-07	2.55e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PIK3CB—obesity	1.91e-07	2.43e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—obesity	1.9e-07	2.4e-06	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—AKT1—obesity	1.87e-07	2.37e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PIK3CA—obesity	1.78e-07	2.26e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PIK3CA—obesity	1.51e-07	1.92e-06	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—AKT1—obesity	1.46e-07	1.85e-06	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—AKT1—obesity	1.23e-07	1.57e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PIK3CA—obesity	1.17e-07	1.48e-06	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—AKT1—obesity	9.52e-08	1.21e-06	CbGpPWpGaD
